NCT00365781View on ClinicalTrials.gov

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

September 30, 2006

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ISIS 113715

Trial Locations (1)

92121

Therapeutics Clinical Research, San Diego

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY